CD274 and cancer: These PD-L1+ EVs, when interacting with immune cells, can inhibit T cell function and induce immune tolerance, much like PD-L1 on the surface of cancer cells.30,35,36 This mechanism further contributes to the immune evasion capabilities of tumors.